| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
HAE
Haemonetics
|
Aug 12, 2026 | BUY |
Buy
-15.0% avg upside
18 analysts
|
$100.00
15.31% Upside
|
+0.0% | · |
|
MOBI
Mobia Medical, Inc.
|
Aug 11, 2026 | BUY |
Strong Buy
+76.1% avg upside
4 analysts
|
$16.00
23.01% Upside
|
· | · |
|
BBNX
Beta Bionics, Inc.
|
Aug 11, 2026 | HOLD |
Strong Buy
+25.5% avg upside
14 analysts
|
$18.00
6.14% Upside
|
+4.3% | · |
|
CBLL
Ceribell, Inc.
|
Aug 11, 2026 | BUY |
Strong Buy
+10.6% avg upside
8 analysts
|
— | +0.0% | · |
|
SOLV
Solventum Corporation
|
Aug 11, 2026 | HOLD |
Buy
+7.5% avg upside
16 analysts
|
$95.00
13.86% Upside
|
+0.7% | · |
|
GEHC
GE Healthcare Technologies Inc
|
Aug 11, 2026 | HOLD |
Strong Buy
+13.5% avg upside
22 analysts
|
$74.00
2.87% Upside
|
+1.2% | · |
|
ZBH
Zimmer Biomet Holdings
|
Aug 11, 2026 | HOLD |
Buy
+17.5% avg upside
38 analysts
|
$110.00
15.23% Upside
|
+1.4% | · |
|
SYK
Stryker
|
Aug 11, 2026 | BUY |
Strong Buy
+6.5% avg upside
37 analysts
|
$380.00
11.17% Upside
|
· | · |
|
ISRG
Intuitive Surgical
|
Aug 11, 2026 | BUY |
Strong Buy
+19.8% avg upside
36 analysts
|
$470.00
17.73% Upside
|
-0.1% | · |
|
BSX
Boston Scientific
|
Aug 11, 2026 | BUY |
Strong Buy
+31.9% avg upside
38 analysts
|
$54.00
6.57% Upside
|
+0.4% | · |
|
BDX
Becton Dickinson
|
Aug 11, 2026 | HOLD |
Buy
+7.4% avg upside
25 analysts
|
$185.00
3.19% Upside
|
· | · |
|
BAX
Baxter International
|
Aug 11, 2026 | HOLD |
Buy
+23.2% avg upside
23 analysts
|
$28.00
4.54% Upside
|
· | · |
|
ABT
Abbott Laboratories
|
Aug 11, 2026 | BUY |
Strong Buy
+3.9% avg upside
36 analysts
|
$115.00
5.15% Upside
|
· | · |
|
EMBC
Embecta Corporation
|
Aug 10, 2026 | SELL |
Hold
+106.3% avg upside
5 analysts
|
— | -1.2% | · |
|
MMED
MiniMed Group, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
+8.6% avg upside
14 analysts
|
$24.00
22.16% Upside
|
· | · |
|
TNDM
Tandem Diabetes Care
|
Aug 07, 2026 | HOLD |
Buy
+40.3% avg upside
29 analysts
|
$25.00
8.66% Upside
|
+3.4% | · |
|
GMED
Globus Medical
|
Aug 07, 2026 | BUY |
Strong Buy
+8.4% avg upside
24 analysts
|
— | +3.4% | · |
|
TFX
Teleflex
|
Aug 07, 2026 | HOLD |
Buy
+38.9% avg upside
20 analysts
|
— | -1.1% | · |
|
CARL
Carlsmed, Inc.
|
Aug 06, 2026 | BUY |
Strong Buy
+37.0% avg upside
6 analysts
|
— | +0.1% | · |
|
RXST
RxSight
|
Aug 05, 2026 | SELL |
Hold
+26.8% avg upside
13 analysts
|
$6.50
6.78% Downside
|
-10.7% | · |
|
SIBN
SI-Bone
|
Aug 04, 2026 | BUY |
Strong Buy
+37.2% avg upside
18 analysts
|
— | +3.0% | · |
|
INSP
Inspire Medical Systems
|
Aug 04, 2026 | SELL |
Buy
+45.9% avg upside
21 analysts
|
$45.00
22.28% Downside
|
+9.1% | · |
|
DXCM
Dexcom
|
Jul 31, 2026 | BUY |
Strong Buy
+16.5% avg upside
32 analysts
|
— | +8.6% | · |
|
MMSI
Merit Medical Systems
|
Jul 31, 2026 | HOLD |
Strong Buy
+8.4% avg upside
15 analysts
|
— | +6.7% | · |
|
BLCO
Bausch + Lomb Corporation
|
Jul 30, 2026 | SELL |
Buy
+19.2% avg upside
19 analysts
|
— | +1.0% | · |
|
CNMD
Conmed
|
Jul 30, 2026 | SELL |
Hold
+30.9% avg upside
12 analysts
|
— | -4.6% | · |
|
EW
Edwards Lifesciences
|
Jul 21, 2026 | BUY |
Strong Buy
+8.1% avg upside
34 analysts
|
$100.00
8.39% Upside
|
+9.4% | · |
|
KMTS
Kestra Medical Technologies Ltd.
|
Jul 16, 2026 | BUY |
Strong Buy
+1.1% avg upside
9 analysts
|
$30.00
9.01% Upside
|
+15.9% | · |
|
MDT
Medtronic
|
Jul 13, 2026 | BUY |
Buy
+6.5% avg upside
38 analysts
|
$95.00
6.67% Upside
|
+7.1% | · |
|
PODD
Insulet
|
Jun 23, 2026 | BUY |
Strong Buy
+50.4% avg upside
32 analysts
|
$208.00
47.50% Upside
|
+0.2% | · |
|
IART
Integra Lifesciences
|
May 14, 2026 | SELL |
Buy
+149.7% avg upside
21 analysts
|
— | -17.9% | · |
|
COO
Cooper Co
|
Mar 05, 2026 | BUY |
Buy
+73.8% avg upside
21 analysts
|
$96.00
27.12% Upside
|
-4.3% | · |
|
PEN
Penumbra
|
Jan 15, 2026 | BUY |
Buy
+1.2% avg upside
23 analysts
|
— | -6.9% | · |
|
PRCT
PROCEPT BioRobotics
|
Nov 05, 2025 | BUY |
Buy
+46.2% avg upside
17 analysts
|
— | -30.8% | · |
|
ITGR
Integer Holdings
|
Oct 24, 2025 | HOLD |
Buy
-18.1% avg upside
16 analysts
|
$87.00
30.41% Downside
|
+71.5% | · |
|
OM
Outset Medical
|
May 13, 2024 | SELL |
Buy
+269.1% avg upside
8 analysts
|
$3.00
36.08% Downside
|
+62.9% | · |
|
LUNG
Pulmonx
|
Sep 29, 2023 | HOLD |
Buy
+218.6% avg upside
9 analysts
|
— | -19.8% | · |
|
DXC
DXC Technology
|
Jan 06, 2021 | SELL |
Hold
+154.5% avg upside
22 analysts
|
$24.00
127.53% Upside
|
-27.5% | · |
|
LNTH
Lantheus
|
Sep 27, 2017 | BUY |
Buy
-18.3% avg upside
21 analysts
|
$22.00
78.14% Downside
|
-17.1% | · |
|
AXGN
AxoGen
|
Sep 25, 2017 | BUY |
Strong Buy
-28.8% avg upside
21 analysts
|
$18.00
62.82% Downside
|
+98.4% | · |
|
VRAYQ
Viewray
|
Aug 07, 2017 | BUY |
Strong Buy
+558333233.3% avg upside
12 analysts
|
— | · | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.